Bone marrow MxA staining reflects anifrolumab response in formerly treatment-refractory systemic lupus erythematosus with initial pancytopenia.
Lupus
View this publicationLupus
View this publicationPain management
View this publicationAIDS (London, England)
View this publicationMolecular medicine (Cambridge, Mass.)
View this publicationExperimental hematology
View this publicationThe Lancet. Rheumatology
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationOxidative medicine and cellular longevity
View this publicationCurrent opinion in neurobiology
View this publicationPloS one
View this publication